"Providing care to Nevadans since 1988, Las Vegas Urology is one of Nevada’s largest urology groups in Southern NevadaWe continually evaluate our services and processes in an effort to improve every aspect of our care, from reception through caregiving. Our goal is to improve your patient experience by making your entire office visit and surgery scheduling seamless. Our single mission is to deliver comprehensive, compassionate urologic care with our state-of-the-art equipment and procedures. As the premier medical group dedicated to urologic care in Southern Nevada, we strive to offer both world-class care and treatment options, as well as consistently superior patient care for those we serve, their family members, and referring physicians."

During the past decade, Las Vegas Prostate Cancer Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 6 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 6 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Las Vegas Prostate Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored and "Eastern Cooperative Oncology Group" with 11 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Las Vegas Prostate Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Las Vegas Prostate Cancer Center" are "Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Anal Basaloid Carcinoma" (3 trials), "Anal Canal Cloacogenic Carcinoma" (3 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Las Vegas Prostate Cancer Center" in a lesser frequency.

Most popular intervention types in "Las Vegas Prostate Cancer Center" are "Drug" (54 trials), "Other" (41 trials), "Biological" (35 trials), "Procedure" (30 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (20 trials), "Computed Tomography" (19 trials), "Quality-of-Life Assessment" (19 trials), "Nivolumab" (13 trials) and "Questionnaire Administration" (13 trials). Other intervention names were less common.

The vast majority of trials in "Las Vegas Prostate Cancer Center" are 66 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Las Vegas Prostate Cancer Center". undefined are not yet recruiting, 36 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Las Vegas Prostate Cancer Center, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Las Vegas Prostate Cancer Center, 1 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".